We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUM icon
26
Yum! Brands
YUM
$40B
$635K 0.73%
7,306
+4,452
+156% +$380K
ANET icon
27
Arista Networks
ANET
$241B
$622K 0.71%
+47,408
New +$641K
RVTY icon
28
Revvity
RVTY
$12.9B
$598K 0.69%
+6,099
New +$558K
TYL icon
29
Tyler Technologies
TYL
$13.1B
$586K 0.67%
+1,689
New +$567K
ZD icon
30
Ziff Davis
ZD
$1.98B
$578K 0.66%
+10,520
New +$688K
CSX icon
31
CSX Corp
CSX
$93.3B
$569K 0.65%
24,465
+14,613
+148% +$323K
MDLZ icon
32
Mondelez International
MDLZ
$78.6B
$558K 0.64%
+10,917
New +$561K
SCHW
33
Charles Schwab
SCHW
$189B
$557K 0.64%
+16,512
New +$591K
RP
34
DELISTED
RealPage, Inc.
RP
$555K 0.64%
8,542
+7,181
+528% +$453K
GGG icon
35
Graco
GGG
$13.5B
$551K 0.63%
+11,477
New +$541K
CPRT icon
36
Copart
CPRT
$27.3B
$550K 0.63%
+26,412
New +$530K
LLY icon
37
Eli Lilly
LLY
$1.08T
$540K 0.62%
3,292
+3,196
+3,329% +$491K
MDT icon
38
Medtronic
MDT
$114B
$540K 0.62%
5,884
+5,005
+569% +$480K
EW icon
39
Edwards Lifesciences
EW
$53.2B
$539K 0.62%
7,806
+2,571
+49% +$183K
GIS icon
40
General Mills
GIS
$19.9B
$538K 0.62%
8,723
+7,970
+1,058% +$481K
CVBF icon
41
CVB Financial
CVBF
$3.95B
$534K 0.61%
+28,486
New +$544K
CAH icon
42
Cardinal Health
CAH
$55.5B
$526K 0.6%
10,070
+9,274
+1,165% +$478K
STZ icon
43
Constellation Brands
STZ
$22.9B
$526K 0.6%
3,004
+1,863
+163% +$310K
DEI icon
44
Douglas Emmett
DEI
$1.9B
$524K 0.6%
+17,083
New +$512K
NSC icon
45
Norfolk Southern
NSC
$75.6B
$520K 0.6%
2,962
+2,350
+384% +$398K
TDY icon
46
Teledyne Technologies
TDY
$32.2B
$506K 0.58%
+1,626
New +$534K
AMD icon
47
Advanced Micro Devices
AMD
$775B
$500K 0.57%
9,504
+6,795
+251% +$360K
EXC icon
48
Exelon
EXC
$46.1B
$499K 0.57%
19,280
+11,383
+144% +$302K
HALO icon
49
Halozyme
HALO
$12.1B
$496K 0.57%
18,496
+16,904
+1,062% +$381K
SWKS icon
50
Skyworks Solutions
SWKS
$10.4B
$496K 0.57%
+3,879
New +$430K
1
2
3 4 5

Similar funds

KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
ACA
Anchorage Capital Advisors New York $378M AUM 13.47% 1-Year Est. Return
AFCM
Alta Fox Capital Management Fort Worth, Texas $378M AUM 59.19% 1-Year Est. Return
DAL
Delta Air Lines Atlanta, Georgia $378M AUM 12.68% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
WAM
Wakefield Asset Management Englewood, Colorado $377M AUM 38.72% 1-Year Est. Return
FP
Fivespan Partners San Francisco, California $377M AUM

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.